JOHNSON & JOHNSON

报告期 2026-03-31 · CIK 0000200406

持仓数

前50大市值合计

$652.4M

报告期

2026-03-31

当前持仓调仓

前 16 大持仓

标的

类型

市值

股数

占比*

PTGX Protagonist Therapeutics Inc.

COM

$258.1M

2,449,183

39.6%

NBTX Nanobiotix S.A.

SPONSORED ADS

$14.7M

814,586

2.3%

XNCR Xencor, Inc.

COM

$9.0M

748,062

1.4%

PRCT Procept BioRobotics Corporation

COM

$9.0M

357,939

1.4%

FATE Fate Therapeutics, Inc.

COM

$4.1M

3,379,064

0.6%

NMRA Neumora Therapeutics, Inc.

COM

$3.6M

1,849,445

0.6%

RLYB Rallybio Corporation

COM

$1.4M

152,901

0.2%

VOR Vor Biopharma, Inc.

COM NEW

$958.6K

53,732

0.1%

LAB Standard BioTools, Inc.

COM

$286.8K

311,967

0.0%

— Nano-X Imaging Ltd.

ORD SHS

$189.7K

83,554

0.0%

ACET Adicet Bio, Inc.

COM NEW

$155.1K

22,779

0.0%

* 占比按本页前 50 大持仓市值合计计算

持仓集中度按前 50 大市值

93%前 6 大占比

PTGX39.6%NBTX26.6%MeiraGTx Holdings plc8.8%RAPP8.6%CVRX5.8%CTNM4.0%